Skip to main content
OXFORD NANOPORE TECHNOLOGIES PLC logo

OXFORD NANOPORE TECHNOLOGIES PLC — Investor Relations & Filings

Ticker · ONT ISIN · GB00BP6S8Z30 LEI · 213800IRWQ2Q6M2CDW55 IL Manufacturing
Filings indexed 371 across all filing types
Latest filing 2021-11-03 Major Shareholding Noti…
Country GB United Kingdom
Listing IL ONT

About OXFORD NANOPORE TECHNOLOGIES PLC

https://nanoporetech.com/

Oxford Nanopore Technologies PLC develops and commercializes a proprietary technology platform for DNA and RNA sequencing. The company's core technology is based on nanopore sensing, which enables the direct, real-time analysis of single molecules. This electronic method facilitates the sequencing of native nucleic acids, generating long-read data without requiring amplification. The platform is uniquely scalable, offering a range of products from portable, pocket-sized devices like the MinION to high-throughput instruments for population-scale projects. This technology provides researchers with immediate access to data, enabling rapid insights across various fields of biological research, including human genetics, cancer research, microbiology, and environmental science.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled with "RNS Number : 2576R" and contains the standard header/footer information associated with RNS (Regulatory News Service) releases from the London Stock Exchange. The content details a "TR-1: Standard form for notification of major holdings" concerning a change in share ownership (Redmile Group, LLC crossing a threshold). This type of mandatory disclosure regarding significant changes in share capital or ownership structure falls directly under the category of regulatory announcements. While it relates to shareholding, the specific form (TR-1) and the context of being an RNS release strongly suggest classification as a general Regulatory Filing (RNS), as 'Major Shareholding Notification' (MRQ) is defined for changes crossing thresholds, and RNS is the general regulatory announcement channel.
2021-11-03 English
PDMR Notification (ESPP) and Director Declaration
Remuneration Information Classification · 99% confidence The document is identified by the 'RNS Number' header and explicitly states it is provided by 'RNS, the news service of the London Stock Exchange'. The content details a transaction by a Person Discharging Managerial Responsibilities (PDMR), specifically the grant of stock options to the Chief Strategy Officer, James Willcocks, and also notes a director appointment change. This type of mandatory disclosure regarding insider transactions and director changes, disseminated via the RNS system, falls under the general category of regulatory announcements. Since there is no more specific category for PDMR/Insider Transaction reporting (like DIRS, which is for Director's Dealing, but this is an option grant notification), and it is a formal regulatory announcement distributed through the official channel, the most appropriate classification is the general Regulatory Filings category (RNS). The document length is short (3678 chars), but it is the primary announcement itself, not an announcement *about* another report, so the RPA rule does not strictly apply here over the specific content type.
2021-11-01 English
Issue of Equity and Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal announcement disseminated via RNS (Regulatory News Service) of the London Stock Exchange. The content explicitly details the 'Issue of Equity' (issuance of 5,219,722 ordinary shares following option exercises) and provides the 'Total Voting Rights' as of October 31, 2021, referencing FCA Disclosure Guidance and Transparency Rule 5.6.1. This combination of share issuance/capital change and mandatory voting rights disclosure strongly points towards a filing related to share capital changes. The most specific category for share issue/capital change is 'SHA' (Share Issue/Capital Change). Although it is distributed via RNS, the core subject matter is the capital structure change, making SHA more precise than the general 'RNS' fallback.
2021-11-01 English
Upgrade to full-year revenue guidance
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and explicitly states it contains 'INSIDE INFORMATION FOR THE PURPOSES OF THE UK VERSION OF THE MARKET ABUSE REGULATION'. It is titled 'Trading update' and announces an 'Upgrade to full-year revenue guidance'. This structure—a brief announcement of financial performance updates released via the Regulatory News Service (RNS) system—is characteristic of an Earnings Release (ER) or a general regulatory announcement. Since it provides key financial performance updates (revenue guidance upgrade) but is not the full, comprehensive report (like a 10-K or IR), 'ER' is the most appropriate classification for a trading update that raises guidance. The presence of the RNS header and footer confirms it is a regulatory disclosure.
2021-10-14 English
Share Incentive Plan, Director/PDMR Transactions
Remuneration Information Classification · 99% confidence The document is an RNS announcement (indicated by 'RNS Number : 0108P' and the closing boilerplate referencing RNS and the London Stock Exchange). The content details the issuance of ordinary shares under a Share Incentive Plan (SIP) and specifically reports transactions by Persons Discharging Managerial Responsibilities (PDMRs) like the CEO and CFO. This type of filing, reporting personal share transactions by directors/executives, directly corresponds to the definition of Director's Dealing (DIRS). Although it involves share issuance, the primary regulatory purpose here is the disclosure of insider transactions under MAR Article 19, not a general capital change announcement (SHA) or a general regulatory filing (RNS).
2021-10-13 English
Exercise of Over-allotment Option
Regulatory Filings Classification · 98% confidence The document is clearly identified as an RNS announcement by the header "RNS Number : 5241O" and the closing statement mentioning RNS as the information provider. The content discusses the exercise of an over-allotment option following an Initial Public Offering (IPO) and the subsequent admission of shares to the London Stock Exchange. This is a regulatory event announcement concerning capital structure/share issuance following a financing event. While it relates to capital (CAP) or share issuance (SHA), the primary function of this specific document, as indicated by the RNS format and its nature as a general regulatory update about the finalization of an offering, fits best under the general regulatory announcement category, RNS, especially since it is not a detailed report or a specific capital change notice like a buyback (POS) or a general share issue (SHA), but rather a post-IPO closing announcement.
2021-10-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.